CoolSculpting: Allergan Cryolipolysis — Effects, Costs and Results

CoolSculpting is the world's best-selling device for non-invasive body contouring based on cryolipolysis technology (also known as fat freezing). Developed and marketed by Allergan Aesthetics — a company of the AbbVie Group — the CoolSculpting brand name has represented clinically proven, FDA-approved fat reduction without a scalpel, without anaesthesia and without downtime for over a decade. Those who want to permanently reduce stubborn fat deposits on the abdomen, hips, thighs or chin without undergoing surgical liposuction will find in CoolSculpting a scientifically validated alternative.

What Is CoolSculpting?

CoolSculpting is a medical procedure for the non-invasive reduction of localised fat deposits through controlled cooling of fatty tissue — a process scientifically known as cryolipolysis. The principle is based on the discovery that fat cells (adipocytes) are far more sensitive to cold than the surrounding tissue such as skin, nerves or muscles. At precisely controlled temperatures between −11°C and −9°C, the fat cells are irreversibly damaged and then initiate a natural cell death process — apoptosis — without causing harm to healthy neighbouring tissue.

The brand name "CoolSculpting" is exclusively reserved for devices and applicators from Allergan Aesthetics. The technology was originally developed at Harvard Medical School by dermatologists Dr Dieter Manstein and Dr R. Rox Anderson, and later brought to market readiness by ZELTIQ Aesthetics. Allergan acquired ZELTIQ in 2017 for approximately USD 2.5 billion. Worldwide, over 11 million CoolSculpting treatments have been performed to date.

How Does CoolSculpting Cryolipolysis Technology Work?

The scientific foundation of cryolipolysis is solid and well documented by numerous clinical studies. The procedure utilises the physiological cryoselectivity of adipocytes: fatty tissue crystallises at significantly higher temperatures than water-rich tissue. While the freezing temperature of cells with high water content (skin cells, muscle cells) lies far below freezing point, the triglyceride-containing vacuoles in fat cells begin to crystallise at temperatures between −5°C and −11°C.

During treatment, the target body area is suctioned between two cooling plates of the applicator. The temperature is lowered within minutes to the therapeutic range and precisely maintained there. The cold forms lipid crystals inside the fat cell that perforate the adipocyte cell membrane from within. These membrane injuries trigger an inflammatory reaction, which in turn initiates apoptosis — the programmed, controlled cell death.

In the following weeks, macrophages migrate into the affected area and phagocytose the destroyed fat cells. The released lipids are transported away via the lymphatic system and ultimately metabolised in the liver. This process is natural, orderly and leaves no scar tissue.

FDA Approvals by Body Zone

Body Zone	FDA Approval Year
Flanks ("love handles")	2010
Abdomen	2012
Inner and outer thighs	2014
Submental fat (double chin)	2015
Bra line / back rolls	2016
Upper arms	2017
Thigh (banana roll)	2018
Knee fat deposits	2020

In the European Union, CoolSculpting holds the CE mark as a Class IIa medical device, which required rigorous review of safety and efficacy by a notified body.

CoolSculpting Elite Applicators

Applicator	Zone	Treatment Time
CoolAdvantage Plus	Abdomen, flanks (large)	35 minutes
CoolAdvantage	Flanks, upper arms, back	35 minutes
CoolAdvantage Petite	Small flanks, chin	35 minutes
CoolMini	Double chin, knees	45 minutes
CoolSmooth Pro	Inner thighs (contact)	75 minutes
CoolPetite	Small zones, banana roll	45 minutes

CoolSculpting vs Generic Cryolipolysis

On the market, CoolSculpting competes with numerous cheaper devices from the Far East marketed under generic names such as "cryolipolysis", "cryo slimming" or "fat freezing". Key differences:

Temperature precision: The CoolSculpting Elite system controls applicator temperature in real time with an accuracy of ±0.1°C. Cheaper devices often work with fixed cooling plates without adaptive control — creating safety risks.
Vacuum application: CoolSculpting applicators use an active vacuum mechanism, ensuring uniform, consistent tissue contact. Inferior devices often use simple clamps with inconsistent results.
Clinical evidence: CoolSculpting has over 80 published clinical studies and years of FDA oversight. Most generic devices have no independent clinical studies.
CoolSculpting Elite: Since 2020, the second-generation system with C-shaped applicators achieves 18% higher fat reduction compared to the previous model and can treat two body zones simultaneously.

Expected Results

CoolSculpting is not an instant procedure. A clear result timeline applies:

Weeks 1–2: The treatment zone may be swollen and touch-sensitive.
Weeks 3–4: Swelling subsides. Some patients notice first slight improvement in body contour.
Weeks 6–8: More pronounced changes become visible — typically 50–70% of the final result.
Weeks 8–12: The final treatment result is largely achieved: 20–25% reduction in subcutaneous fat layer thickness.
Up to month 6: Further subtle improvements are possible as macrophage clearance can continue for up to six months.

CoolSculpting is not a weight loss procedure. The goal is body contouring: a slimmer, smoother silhouette in the treated area. Patients with a BMI under 30 and clearly defined, localised fat deposits report the highest satisfaction.

Paradoxical Adipose Hyperplasia (PAH) — Risk to Know

Paradoxical adipose hyperplasia (PAH) is the most serious known complication of CoolSculpting. Instead of apoptosis and fat reduction, reactive proliferation of fatty tissue occurs — the treated area enlarges and takes on the shape of the applicator (the "stick butter" phenomenon).

Key facts about PAH:

Appears typically 2–6 months after treatment
Actual incidence: 0.025–0.39% (significantly higher than originally communicated)
Higher risk: male patients, abdominal treatments, older applicators, Hispanic ethnicity
Does not resolve spontaneously — only surgical liposuction can correct it
Reputable providers inform patients about PAH risk before treatment

Treatment Costs

Treatment Zone	Applicators Needed	Approx. Cost
Double chin	1–2	€400–€900
Flanks	2–4	€600–€1,400
Abdomen	2–4	€800–€1,800
Inner thighs	2	€600–€1,200
Upper arms	2–4	€600–€1,400
Full abdomen and flanks	4–6	€1,500–€3,000

Health insurance does not cover CoolSculpting treatments, as these are elective aesthetic procedures. Clinics certified by Allergan often offer package prices for multiple zones. Always ensure the practice uses the original CoolSculpting Elite system and holds current Allergan certification.

Frequently Asked Questions

How many sessions are needed? For smaller, well-defined zones, one session can often deliver adequate results. For larger zones such as the entire abdomen, 2–4 sessions per zone are typically required. A minimum interval of 8 weeks between sessions in the same zone should be maintained.

Who is suitable for CoolSculpting? Best candidates have a BMI under 30, are at or near their target weight, and have clearly palpable, localised fat deposits that are resistant to diet and exercise. CoolSculpting is not suitable for treating visceral (internal) fat, obesity or significant skin laxity.

Is CoolSculpting painful? Most patients experience intense cold, pulling and occasional mild stinging at the applicator site during the first 5–10 minutes. These sensations subside as the cold induces numbness. The treatment requires no anaesthesia.